Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

Company Growth (employees)
Paris, FR
Size (employees)
106,859 (est)
Sanofi was founded in 2004 and is headquartered in Paris, FR

Key People/Management at Sanofi

Olivier Brandicourt

Olivier Brandicourt

Olivier Charmeil

Olivier Charmeil

Executive Vice President and General Manager
Jerome Contamine

Jerome Contamine

Executive Vice President & Chief Financial Officer
Karen Linehan

Karen Linehan

Executive Vice President, Legal Affairs and General Counsel
David Loew

David Loew

Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan

Philippe Luscan

Executive Vice President, Global Industrial Affairs
Alan Main

Alan Main

Executive Vice President, Consumer Healthcare
Muzammil Mansuri

Muzammil Mansuri

Executive Vice President, Strategy & Business Development
Ameet Nathwani

Ameet Nathwani

Executive Vice President, Medical Affairs
Roberto Pucci

Roberto Pucci

Executive Vice President, Human Resources
Elias Zerhouni

Elias Zerhouni

President, Global Research & Development

Sanofi Office Locations

Sanofi has offices in Paris, Bridgewater, Macquarie Park, Ontario and in 9 other locations
Paris, FR (HQ)
54, rue La Boétie
Macquarie Park, AU
Building D, 12-24 Talavera Road
Ontario, CA
1755 Steeles avenue West
Beijing, CN
7th floor, n°112, Jian Guo Lu, Chaoyang District
Hong Kong, HK
Room 2504-2511, Windsor House, 311, Gloucester Road, Causeway Bay
Bridgewater, US
55 Corporate Drive
Show all (13)

Sanofi Financials and Metrics

Sanofi Financials

Sanofi's revenue was reported to be €37.1 b in FY, 2015 which is a 10% increase from the previous period.

Revenue (FY, 2015)

37.1 b

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

26.1 b

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

4.4 b

Market capitalization (31-Oct-2017)

102.1 b

Closing share price (31-Oct-2017)

Sanofi's current market capitalization is €102.1 b.
EURFY, 2013FY, 2014FY, 2015


33 b33.8 b37.1 b

Revenue growth, %


Cost of goods sold

10.3 b10.2 b10.9 b

Gross profit

22.6 b23.5 b26.1 b
EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4 b6.3 b7.2 b
EURY, 2015


365.4 k
Show all financial metrics

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Phase III Trials


Projects in R&D Pipeline


Drugs Approved by FDA

Show all operating metrics

Sanofi Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Ablynx January 29, 2018$4.8 b
Bioverativ January 22, 2018$11.6 b

Sanofi Market Value History

Sanofi Revenue Breakdown

Sanofi Median Salaries

Source: 9 public H-1B filings from Sanofi

Sanofi's Web-traffic and Trends

Sanofi Online and Social Media Presence

Sanofi Company Life and Culture

You may also be interested in